Capital Performance Advisors’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Sell
3,828
-6,970
-65% -$502K 0.02% 216
2026
Q1
$682K Sell
10,798
-12
-0.1% -$845 0.05% 172
2025
Q4
$730K Buy
10,810
+666
+7% +$44.5K 0.05% 159
2025
Q3
$628K Buy
10,144
+3,684
+57% +$202K 0.1% 104
2025
Q2
$319K Sell
6,460
-2,780
-30% -$114K 0.06% 150
2025
Q1
$303K Buy
+9,240
New +$315K 0.07% 156
2024
Q4
– Sell
-698
Closed -$22.7K – 323
2024
Q3
$22.7K Buy
+698
New +$22.6K 0.01% 570

Other funds holding APH

Capital Performance Advisors's APH Position: Q2 2026 in Review

Capital Performance Advisors reduced its Amphenol (APH) stake by 65% in Q2 2026, selling an estimated $502K and leaving 3,828 shares worth $337K. The position accounts for 0.02% of the portfolio, ranked #216.

Capital Performance Advisors first reported a position in APH in Q3 2024 and has held it in 7 quarters since. The position peaked at $730K in Q4 2025. 2,340 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • Capital Performance Advisors held 3,828 shares of Amphenol worth $337K as of Q2 2026.
  • Capital Performance Advisors sold 6,970 Amphenol shares in Q2 2026, an estimated $502K.
  • Amphenol made up 0.02% of Capital Performance Advisors's portfolio in Q2 2026, its #216 holding.
  • Capital Performance Advisors first reported a position in Amphenol in Q3 2024 and has held it in 7 quarters since.
  • Capital Performance Advisors's Amphenol position peaked at $730K in Q4 2025.
  • 2,340 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.